Founded in 2024 by former Factorial executives Francesc Navarro, Emilio Rodríguez, and Sergio Mosquera, Holo delivers an all-in-one preventive-health platform that lets users book comprehensive lab tests, sync wearables such as Apple Watch, Garmin, and Oura, and receive doctor-reviewed reports grounded in functional medicine. The service maps more than 110 biomarkers—covering inflammation, hormones, longevity indicators, and more—into a dynamic personal health dashboard designed to flag risks before symptoms appear and to optimise daily performance. Integrated AI interprets the combined biomarker and wearable data to generate personalised recommendations, positioning Holo as a “Revolut of health” for everyday consumers. The company currently partners with Laboratorios Echevarne in Spain and plans to add further medical integrations and clinical collaborations across Europe. Proceeds from its recent financing will fund continued product development, new medical modules, and expansion within Spain ahead of a broader European launch slated for 2026. Although still pre-revenue and early in user acquisition, Holo aims to capitalise on growing consumer demand for proactive, longevity-focused healthcare solutions. Its mission is to become Europe’s leading preventive-health and longevity platform.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Nov 2025